Effects of Synbiotic Supplementation on Bone and Metabolic Health in Postmenopausal Women
Overview
This study explores how a synbiotic supplement can help improve bone and metabolic health in Caucasian postmenopausal women. The OsteoPreP trial will last for 12 months and aims to see if this supplement can prevent bone loss and improve overall health.
Study Details
The trial involves 160 postmenopausal women who do not have osteoporosis or are not currently taking any bone-affecting treatments. Participants will undergo scans to ensure they do not have osteoporosis before starting the trial.
Key Goals
- Primary Goal: Measure the change in bone density in the tibia after 12 months.
- Secondary Goals: Assess effects on the immune system, cognition, gut health, and blood sugar levels.
Importance of the Trial
This trial will provide valuable information on the safety and effectiveness of a synbiotic supplement that includes both types of bacteria and prebiotic fiber. The findings could lead to new strategies for preventing osteoporosis and managing metabolic issues in postmenopausal women.
Clinical Relevance
Clinical trials are essential for developing safe treatments. Our AI-driven platform, DocSym, combines clinical guidelines and research to support healthcare providers in delivering effective care.
Streamlining Healthcare
In today’s medical landscape, efficiency is key. Our mobile apps assist with scheduling, treatment monitoring, and telemedicine, simplifying patient management and expanding digital services.
Enhancing Patient Care
By leveraging AI, clinics can improve workflows, enhance patient outcomes, and reduce paperwork. Discover how we can assist you at aidevmd.com.
